Optimeos Life Sciences Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1M
- Investors
-
9
Optimeos Life Sciences General Information
Description
Developer of encapsulation technology-based drugs designed to use biologics, peptides, and RNA to treat disease. The company addresses current issues with many biologics and peptide therapeutics by protecting and delivering agents to their intended targets in the body, enabling pharmaceutical and biotech companies to get sustained delivery of peptide therapeutics using nanocomposite microparticles.
Contact Information
Website
www.optimeos.comCorporate Office
- 174 Nassau Street
- Suite 334
- Princeton, NJ 08542
- United States
Corporate Office
- 174 Nassau Street
- Suite 334
- Princeton, NJ 08542
- United States
Optimeos Life Sciences Timeline
Optimeos Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC | 03-Jun-2026 | $1M | Completed | Generating Revenue | ||
| 14. Secondary Transaction - Private | 01-May-2025 | Completed | Generating Revenue | |||
| 13. Grant | 01-Jan-2025 | Completed | Generating Revenue | |||
| 12. Seed Round | 26-Nov-2024 | Completed | Generating Revenue | |||
| 11. Grant | 01-Jan-2024 | Completed | Generating Revenue | |||
| 10. Grant | 01-Jan-2023 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jun-2022 | Completed | Generating Revenue | |||
| 8. Grant | 05-Sep-2021 | Completed | Generating Revenue | |||
| 7. Seed Round | 01-Jun-2021 | $175K | $1.75M | Completed | Generating Revenue | |
| 6. Accelerator/Incubator | 01-Apr-2021 | $1.57M | Completed | Generating Revenue |
Optimeos Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 63,895 | $0.000100 | $3.13 | $3.13 | 1x | $3.13 | 2.51% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Optimeos Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Optimeos Life Sciences Patents
Optimeos Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026106695-A1 | Targeted nanoparticles encapsulating water-soluble therapeutics, methods of production, and use | Pending | 13-Nov-2024 | ||
| AU-2022419468-A1 | Nanoparticles and methods of production for the encapsulation of nucleic acids | Pending | 23-Dec-2021 | ||
| CA-3241414-A1 | Nanoparticles and methods of production for the encapsulation of nucleic acids | Pending | 23-Dec-2021 | ||
| EP-4452229-A2 | Nanoparticles and methods of production for the encapsulation of nucleic acids | Pending | 23-Dec-2021 | ||
| EP-4452229-A4 | Nanoparticles and methods of production for the encapsulation of nucleic acids | Pending | 23-Dec-2021 | A61K9/5153 |
Optimeos Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Optimeos Life Sciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hatch Biofund Management | Venture Capital | Minority | ||
| 7G Bioventures | Venture Capital | Minority | ||
| Anzu Partners | Venture Capital | Minority | ||
| JSR Life Sciences | Corporation | Minority | ||
| U.S. Department of Health and Human Services | Government |
Optimeos Life Sciences FAQs
-
When was Optimeos Life Sciences founded?
Optimeos Life Sciences was founded in 2016.
-
Where is Optimeos Life Sciences headquartered?
Optimeos Life Sciences is headquartered in Princeton, NJ.
-
What is the size of Optimeos Life Sciences?
Optimeos Life Sciences has 5 total employees.
-
What industry is Optimeos Life Sciences in?
Optimeos Life Sciences’s primary industry is Biotechnology.
-
Is Optimeos Life Sciences a private or public company?
Optimeos Life Sciences is a Private company.
-
What is Optimeos Life Sciences’s current revenue?
The current revenue for Optimeos Life Sciences is .
-
How much funding has Optimeos Life Sciences raised over time?
Optimeos Life Sciences has raised $7.75M.
-
Who are Optimeos Life Sciences’s investors?
Hatch Biofund Management, 7G Bioventures, Anzu Partners, JSR Life Sciences, and U.S. Department of Health and Human Services are 5 of 9 investors who have invested in Optimeos Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
